Stocks
News
ETFs
Economy
Currencies
Press Releases
Prothena Corporation plc - Ordinary Shares (PRTA)
Last Price
6.5800
Change
+0.0300 (0.46%)
NASDAQ
· Last Trade: May 24th, 1:03 PM EDT
Quote
News
Press Releases
Chart
Historical
FAQ
About
Competitors
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
Via
Benzinga
· May 23, 2025
Top movers in Friday's after hours session
chartmill.com
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
· May 23, 2025
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
Via
Benzinga
· May 16, 2025
Beyond The Numbers: 7 Analysts Discuss Prothena Corp Stock
benzinga.com
Via
Benzinga
· May 9, 2025
Earnings Scheduled For May 8, 2025
benzinga.com
Via
Benzinga
· May 8, 2025
A Look Ahead: Prothena Corp's Earnings Forecast
benzinga.com
Via
Benzinga
· May 7, 2025
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
benzinga.com
Via
Benzinga
· February 24, 2025
Earnings Scheduled For February 20, 2025
benzinga.com
Via
Benzinga
· February 20, 2025
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter
benzinga.com
Via
Benzinga
· May 9, 2025
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Via
Benzinga
· February 26, 2025
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings)
benzinga.com
Via
Benzinga
· February 7, 2025
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
benzinga.com
Via
Benzinga
· January 28, 2025
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
Via
Benzinga
· December 20, 2024
Demystifying Prothena Corp: Insights From 6 Analyst Reviews
benzinga.com
Via
Benzinga
· December 20, 2024
Expert Ratings For Prothena Corp
benzinga.com
Via
Benzinga
· November 13, 2024
Earnings Scheduled For November 12, 2024
benzinga.com
Via
Benzinga
· November 12, 2024
Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease
investors.com
The drug technically missed the study's primary goal. But there's still promise it could work in specific patients.
Via
Investor's Business Daily
· December 19, 2024
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits
benzinga.com
Prothena and Roche report Phase 2b PADOVA results on prasinezumab in Parkinson's, showing promising trends and nominal significance in key analyses.
Via
Benzinga
· December 19, 2024
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday
benzinga.com
Via
Benzinga
· December 19, 2024
Earnings Preview For Prothena Corp
benzinga.com
Via
Benzinga
· November 11, 2024
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
benzinga.com
Via
Benzinga
· October 28, 2024
Breaking Down Prothena Corp: 4 Analysts Share Their Views
benzinga.com
Via
Benzinga
· October 1, 2024
Dow Dips 300 Points; Emcore Shares Spike Higher
benzinga.com
Via
Benzinga
· September 30, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Via
Benzinga
· September 30, 2024
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
benzinga.com
Via
Benzinga
· September 30, 2024
